These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1577 related items for PubMed ID: 19326433

  • 1. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G, Abarca J, Bustos V, Riquelme E, Noriega V, Moya C, Campusano J.
    J Neurosci Res; 2009 Aug 01; 87(10):2308-18. PubMed ID: 19326433
    [Abstract] [Full Text] [Related]

  • 2. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B, Relova JL, Gallego R, Ben-Batalla I, Perez-Fernandez R.
    J Neurosci Res; 2009 Feb 15; 87(3):723-32. PubMed ID: 18816795
    [Abstract] [Full Text] [Related]

  • 3. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats.
    Robinson S, Krentz L, Moore C, Meshul CK.
    Synapse; 2001 Oct 15; 42(1):54-61. PubMed ID: 11668591
    [Abstract] [Full Text] [Related]

  • 4. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):155-61. PubMed ID: 15790539
    [Abstract] [Full Text] [Related]

  • 5. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain.
    Bustos G, Abarca J, Campusano J, Bustos V, Noriega V, Aliaga E.
    Brain Res Brain Res Rev; 2004 Dec 24; 47(1-3):126-44. PubMed ID: 15572168
    [Abstract] [Full Text] [Related]

  • 6. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
    Geng SJ, Liao FF, Dang WH, Ding X, Liu XD, Cai J, Han JS, Wan Y, Xing GG.
    Exp Neurol; 2010 Apr 24; 222(2):256-66. PubMed ID: 20079352
    [Abstract] [Full Text] [Related]

  • 7. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Enna SJ, Reisman SA, Stanford JA.
    Neurosci Lett; 2006 Oct 02; 406(1-2):102-6. PubMed ID: 16890350
    [Abstract] [Full Text] [Related]

  • 8. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
    Turner MS, Gray TS, Mickiewicz AL, Napier TC.
    Brain Struct Funct; 2008 Sep 02; 213(1-2):197-213. PubMed ID: 18663473
    [Abstract] [Full Text] [Related]

  • 9. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA, Wüllner U, Heneka MT, Schulz JB, Kunow M, Wachtel H, Klockgether T.
    Synapse; 1997 Aug 02; 26(4):381-91. PubMed ID: 9215597
    [Abstract] [Full Text] [Related]

  • 10. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
    Abarca J, Bustos G.
    Neurochem Int; 1999 Jul 02; 35(1):19-33. PubMed ID: 10403427
    [Abstract] [Full Text] [Related]

  • 11. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ, Batchelor PE, Howells DW.
    Exp Neurol; 2005 Mar 02; 192(1):226-34. PubMed ID: 15698637
    [Abstract] [Full Text] [Related]

  • 12. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B, Kozlowski DA, Unnerstall JR, Elsworth JD, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2001 May 02; 169(1):83-95. PubMed ID: 11312561
    [Abstract] [Full Text] [Related]

  • 13. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury.
    Canudas AM, Pezzi S, Canals JM, Pallàs M, Alberch J.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):147-54. PubMed ID: 15790538
    [Abstract] [Full Text] [Related]

  • 14. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
    Wang YQ, Bian GL, Bai Y, Cao R, Chen LW.
    Neurochem Int; 2008 Sep 24; 53(3-4):56-62. PubMed ID: 18639597
    [Abstract] [Full Text] [Related]

  • 15. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
    Moroz IA, Peciña S, Schallert T, Stewart J.
    Exp Neurol; 2004 Sep 24; 189(1):78-93. PubMed ID: 15296838
    [Abstract] [Full Text] [Related]

  • 16. Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat.
    Kozlowski DA, Miljan EA, Bremer EG, Harrod CG, Gerin C, Connor B, George D, Larson B, Bohn MC.
    Brain Res; 2004 Aug 06; 1016(2):170-81. PubMed ID: 15246853
    [Abstract] [Full Text] [Related]

  • 17. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD, Manzino L, Sonsalla PK.
    Exp Neurol; 2000 Feb 06; 161(2):638-46. PubMed ID: 10686083
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B, Kozlowski DA, Schallert T, Tillerson JL, Davidson BL, Bohn MC.
    Gene Ther; 1999 Dec 06; 6(12):1936-51. PubMed ID: 10637445
    [Abstract] [Full Text] [Related]

  • 19. The excitoprotective effect of N-methyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons.
    Jiang X, Tian F, Mearow K, Okagaki P, Lipsky RH, Marini AM.
    J Neurochem; 2005 Aug 06; 94(3):713-22. PubMed ID: 16000165
    [Abstract] [Full Text] [Related]

  • 20. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
    Smith AD, Kozlowski DA, Bohn MC, Zigmond MJ.
    Exp Neurol; 2005 Jun 06; 193(2):420-6. PubMed ID: 15869944
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 79.